Investor Insights

This summary was created by AI, based on 1 opinions in the last 12 months.

According to experts, LNTH has seen solid revenue and earnings growth in the past few years, but its share price has been under pressure recently due to weak preliminary results for FY2023. The company has a strong balance sheet with minimal net debt and has been reinvesting heavily for growth. Sales are expected to grow by around 9% over the next few years. While the momentum is poor, the valuation is considered quite attractive, although there is a possibility of it being a value trap. Experts suggest waiting for growth to pick up or for the momentum to improve before considering adding this stock to the portfolio.

Consensus
Neutral
Valuation
Fair Value
DON'T BUY
Lantheus
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

LNTH is now trading at 9.1x times' Forward P/E. In the last few years, revenue and earnings growth were solid, but the share price has been under pressure recently after the company gave out weak preliminary result for FY2023. The balance sheet is strong, with a net debt of only $3M. The company has been reinvesting heavily in the last two years to pursue growth, along with some minor buybacks. Based on consensus estimates, sales are expected to grow by around 9% over the next few years. LNTH is a bit  different from LLY and ABBV, which are drug development companies.  The momentum is quite poor but we think valuation is quite attractive. It might be a value trap, and we would be less inclined to add until growth picks up or momentum improves. 
Unlock Premium - Try 5i Free

Healthcare
PARTIAL SELL
Lantheus
The stock has been a rocket ship and is not overvalued. Take profits
Healthcare
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Lantheus(LNTH-Q) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 1

Stockchase rating for Lantheus is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Lantheus(LNTH-Q) Frequently Asked Questions

What is Lantheus stock symbol?

Lantheus is a American stock, trading under the symbol LNTH-Q on the NASDAQ (LNTH). It is usually referred to as NASDAQ:LNTH or LNTH-Q

Is Lantheus a buy or a sell?

In the last year, 1 stock analyst published opinions about LNTH-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Lantheus.

Is Lantheus a good investment or a top pick?

Lantheus was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Lantheus.

Why is Lantheus stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Lantheus worth watching?

In the last year, there was no coverage of Lantheus published on Stockchase.

What is Lantheus stock price?

On 2024-03-28, Lantheus (LNTH-Q) stock closed at a price of $62.21.